These innovative treatments, Semaglutide , represent a remarkable advancement in treating obesity and potentially associated conditions . These drugs are categorized as GLP-1 receptor agonists , https://henrixzwq558674.luwebs.com/42276417/tirzepatide-a-thorough-exploration-into-glp-1-copyright